Article Details

Ultragenyx's Glycogen Storage Disease Gene Therapy DTX401 Continues to Enable ... - CGTLive®

Retrieved on: 2025-09-16 21:38:24

Tags for this article:

Click the tags to see associated articles and topics

Ultragenyx's Glycogen Storage Disease Gene Therapy DTX401 Continues to Enable ... - CGTLive®. View article details on hiswai:

Excerpt

In comparison to previously reported 48-week data, the 96-week data showed that patients in both the ongoing DTX401 group and the crossover ...

Article found on: www.cgtlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo